Tract Bio, a biotechnology company focused on developing novel therapies for cancer and inflammatory diseases, has officially opened its new laboratory in Charlotte, North Carolina. The lab is located at Connect Labs by Wexford within Atrium Health’s innovation district, The Pearl. The company celebrated the opening yesterday and plans a grand opening event at Connect Labs Charlotte in early 2026.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 7 November 2025
The new state-of-the-art laboratory provides advanced infrastructure to support Tract’s research and development programs and its ongoing growth. By establishing a presence at The Pearl, Tract gains access to world-class scientific resources and collaboration opportunities within a dynamic biotechnology ecosystem. The location positions the company to accelerate its research initiatives while connecting with leading experts in the life sciences community.
Richard Russell, Chief Executive Officer of Tract Bio, said the lab represents a major milestone for the company and underscores its commitment to developing treatments for patients with cancer and inflammatory diseases. He added that being part of The Pearl allows Tract to leverage cutting-edge scientific and clinical expertise and a vibrant life science community, which will help the company expand its team and advance its mission to address critical areas of unmet medical need.
Health Technology Insights: LISCure Starts Global Phase 2 Trial of LB-P8 in PSC
Connect Labs by Wexford, developed and managed by Wexford Science & Technology, offers flexible, scale-in-place laboratory and innovation spaces for emerging and growth companies in life sciences, engineering, computational, and energy sectors. Craig Scharton, Director of Connect Labs Charlotte, said the addition of Tract Bio reflects the district’s collaborative energy and commitment to advancing biomedical innovation. He emphasized that Connect Labs was designed to bring together advanced technology, medical expertise, and visionary companies to accelerate discoveries from concept to commercialization.
Alongside the move, Tract’s scientific co-founders, Frank McKeon, Ph.D., and Wa Xian, Ph.D., have joined Wake Forest University School of Medicine as professors of Cancer Biology at its Charlotte campus. The campus, situated within The Pearl, represents Charlotte’s first four-year medical school and offers new opportunities for academic collaboration in cutting-edge cancer research.
This expansion strengthens Tract Bio’s ability to advance innovative therapies while integrating with a thriving local and national scientific network, reinforcing the company’s dedication to transforming patient care in areas of high unmet need.
Health Technology Insights: MY DR NOW Opens New Clinic at 24th Street and Baseline
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
